Médecins Sans Frontières
By
Médecins Sans Frontières
Published: Nov. 25, 2020, 3:33 p.m.·
Tags:
Global TB response,
Advocacy
Médecins Sans Frontières conducted a webinar on 25 November 2020 reviewing the findings of the recently released report Step Up for TB 2020: Tuberculosis Policies in 37 Countries.
Read More →
By
Stop TB Partnership,
Médecins Sans Frontières
Published: Nov. 16, 2020, 1:44 p.m.·
Tags:
Global TB response,
Advocacy
Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.
Read More →
By
Médecins Sans Frontières
Published: July 6, 2020, 12:21 a.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
120,707 people signed petitions urging the corporation to drop the price.
Read More →
By
Médecins Sans Frontières
Published: March 24, 2020, 11:29 p.m.·
Tags:
Global TB response,
Advocacy
As the world grapples with the global pandemic of coronavirus, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide, like people with tuberculosis (TB), whose lungs are often damaged and immune systems weakened.
Read More →
By
Treatment Action Group,
Médecins Sans Frontières,
Health GAP
Published: Jan. 30, 2020, 12:41 a.m.·
Tags:
Advocacy
Treatment Action Group, Médecins Sans Frontières and Health GAP conducted a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.
Read More →
By
Médecins Sans Frontières
Published: Jan. 22, 2020, 1:20 a.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.
Read More →
By
Treatment Action Group,
Médecins Sans Frontières,
Health GAP
Published: Dec. 19, 2019, 11:15 a.m.·
Tags:
Advocacy
Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.
Read More →
By
GCTA,
Médecins Sans Frontières,
Treatment Action Group
Published: Oct. 31, 2019, 5:23 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.
Read More →
By
Médecins Sans Frontières
Published: Oct. 30, 2019, 4:32 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world.
Read More →
Page 1 of 8 · Total posts: 10
1
2
Last→